OTUD7B and breast carcinoma: Our data showed that OTUD7B upregulation was significantly associates with a poor RFS rate in patients with HER2-positive and basal-like breast cancers (Figure 5E and 5F); the worst HR was observed in patients with basal-like breast cancer compared to other subtypes (Figure 5F).